Top compounds associated with response to TXNDC17


Feature Type Standardized
Nominal ANOVA
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.078 0.01
mRNA Bleomycin CTRPv2 pan-cancer AAC 0.096 0.01
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.11 0.01
mRNA barasertib CTRPv2 pan-cancer AAC -0.081 0.01
mRNA ruxolitinib GDSC1000 pan-cancer AAC 0.084 0.01
mRNA 16-beta-bromoandrosterone CTRPv2 pan-cancer AAC -0.095 0.01
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA SCH-79797 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA TAE684 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC 0.084 0.01
Download CSV